Neuronetics Inc (STIM)
0.75
-0.03
(-3.85%)
USD |
NASDAQ |
Sep 27, 16:00
0.7875
+0.04
(+5.00%)
Pre-Market: 20:00
Neuronetics Research and Development Expense (Annual): 9.515M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 9.515M |
| December 31, 2022 | 9.336M |
| December 31, 2021 | 7.923M |
| December 31, 2020 | 9.201M |
| Date | Value |
|---|---|
| December 31, 2019 | 13.75M |
| December 31, 2018 | 8.232M |
| December 31, 2017 | 7.937M |
| December 31, 2016 | 8.223M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
7.923M
Minimum
2021
13.75M
Maximum
2019
9.944M
Average
9.336M
Median
2022
Research and Development Expense (Annual) Benchmarks
| Quest Diagnostics Inc | -- |
| Delcath Systems Inc | 17.50M |
| Star Equity Holdings Inc | -- |
| CytoSorbents Corp | 15.73M |
| Progyny Inc | -- |